Evaluation of the Anti-Cancer Effects of KMU-11342 in In Vitro and Ex Vivo Models of Colorectal Cancer
Jieun Jeon, Jeongin Jang, Chae Young Moon, Jinho Lee, Victor Sukbong Hong, Hyunju Kang, Jee Young Park, Na Hyeon Heo, Jong-Wook Park, Jae-Hyung Park, Jae-Ho Lee, Hye Won Lee, Sung Uk Bae, Hyunsu Lee, Shin Kim · 2026
Read Evaluation of the Anti-Cancer Effects of KMU-11342 in In Vitro and Ex Vivo Models of Colorectal Cancer by Jieun Jeon, Jeongin Jang, Chae Young Moon, Jinho Lee, Victor Sukbong Hong, Hyunju Kang, Jee Young Park, Na Hyeon Heo, Jong-Wook Park, Jae-Hyung Park, Jae-Ho Lee, Hye Won Lee, Sung Uk Bae, Hyunsu Lee, Shin Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13415177.txt.
Description
Jieun Jeon and colleagues test a kinase blocking compound, KMU-11342, against colorectal cancer in 2026 laboratory and tissue models. The compound had earlier shown anti-inflammatory effects. Tests covered flat cell cultures, three-dimensional spheroids, and organoids grown from patient tumors.
Cell density fell by about 59 percent at a half micromolar dose and about 83 percent at one micromolar. Treated cells stalled before division and died by apoptosis, the controlled cell death route. Organoids lost about 39 percent viability at one micromolar and about 77 percent at two. Computer docking pointed to two kinases, GSK3 beta and CDK1, as likely targets.
Catalog record
| CREATOR | Jieun Jeon, Jeongin Jang, Chae Young Moon, Jinho Lee, Victor Sukbong Hong, Hyunju Kang, Jee Young Park, Na Hyeon Heo, Jong-Wook Park, Jae-Hyung Park, Jae-Ho Lee, Hye Won Lee, Sung Uk Bae, Hyunsu Lee, Shin Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42484 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |